Delivery Order SPE2DB22D2006-SPE2DB25FV8TZ
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$39K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,451.30 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (0.25-0.5 mg/dose) pens, a medication used to treat diabetes. The contract has an ultimate completion date of July 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive...
This is a $17,258.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $12,685.72 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Ozempic 0.25-0.5 mg/dose pens, a specialty medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a $16,944.78 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a diabetes medication, to support military healthcare programs. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides a comprehensive range of...
This is a $10,512.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of July 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a $38,069.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml, a medication used for diabetes management. The contract has a period of performance through May 17, 2023. There is no set-aside designation mentioned for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a $17,621.56 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,572.03 delivery order contract is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a medication used for diabetes management. The contract has a completion date of February 19, 2025 and is a firm fixed-price contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $20,602.61 delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract is firm fixed price and has a completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.74 firm fixed-price contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...